**Core Concept**
The management of trigeminal neuralgia involves the use of anticonvulsant and antidepressant medications to reduce or block the pain signals sent to the brain. **Carbamazepine** is often considered a first-line treatment due to its efficacy in reducing or eliminating the pain associated with this condition.

**Why the Correct Answer is Right**
Although the exact correct answer is not provided, typically, **Carbamazepine** is the drug of choice for trigeminal neuralgia. It acts by stabilizing inactivated sodium channels, which reduces the repetitive firing of neurons and thereby reduces the pain.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option provided, it's challenging to give a precise reason. However, any option other than a well-established anticonvulsant or a medication known to be effective in neuropathic pain would be incorrect.
**Option B:** Similarly, without specifics, if this option does not align with known treatments for trigeminal neuralgia, such as **Oxcarbazepine** or **Gabapentin**, it would be incorrect.
**Option C:** and **Option D:** would be incorrect for the same reasons, lacking alignment with established therapies.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that while **Carbamazepine** is a first-line treatment, patients should be monitored for side effects, and alternative therapies should be considered if it is not tolerated or effective.

**Correct Answer:** Correct Answer: D. Carbamazepine.